220 Participants Needed

Visual Tools for Prostate Cancer

Recruiting at 1 trial location
DU
TG
Overseen ByTaylor Greene
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: UNC Lineberger Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if visual tools can improve conversations between doctors and patients regarding the risks and benefits of surgery for prostate and kidney cancer. The research will explore how these tools might influence the advice doctors provide and how patients perceive their discussions. The trial will also examine whether these changes differ among various races and healthcare settings. Patients newly diagnosed with localized prostate cancer or a T1 renal mass in the past six months may be suitable candidates for this study. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance doctor-patient communication.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinator or your doctor.

What prior data suggests that this visual decision support is safe for use in patient-provider communication?

Research has shown that visual tools in medical settings are generally safe for both patients and doctors. These tools help doctors explain treatment options more clearly. Studies have found that visual aids improve communication and understanding without causing harm.

One study on visual tools for prostate cancer care found that these aids enhanced understanding of treatment outcomes for both patients and doctors. The visuals did not negatively affect patient safety but made complex medical information easier to grasp.

Another study used visual timelines to help prostate cancer patients track their health over time. This method was well received and did not cause safety issues.

Overall, visual tools are well-tolerated. They improve the quality of care by making medical information clearer and easier to discuss, without introducing risks.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores using visual tools to improve communication and decision-making for prostate cancer treatment. Unlike traditional medical approaches that mainly focus on drug or surgical interventions, this method emphasizes enhancing understanding between patients and physicians. By utilizing visual aids, the trial aims to make complex medical information more accessible, potentially leading to better patient outcomes and satisfaction.

What evidence suggests that this visual decision support is effective for prostate cancer?

This trial will evaluate the use of visual tools for prostate cancer. Studies have shown that visual tools can help prostate cancer patients better understand complex information. For instance, visual timelines clearly display a patient's health data over time. Research suggests these tools make it easier for patients to manage their health and compare their outcomes with others. However, not all visual aids are equally helpful; some studies found no improvement in patients' understanding of their prognosis. Better visual aids are expected to help doctors and patients discuss the risks and benefits of surgery more effectively, potentially improving communication between patients and their healthcare providers.35678

Who Is on the Research Team?

HT

Hung-Jui Tan, MD

Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This trial is for urologists treating patients with newly diagnosed localized prostate and kidney cancer. It aims to include up to 20 surgeons from both academic and community settings, targeting a total of 200 unique patient visits.

Inclusion Criteria

Verbal informed consent was obtained to participate in the study
For physician subjects, practicing urologist in North Carolina at UNC Health, Novant Health, or an affiliated site and sees patients with suspected or confirmed prostate or kidney cancer
I am willing and able to follow the study's requirements.
See 1 more

Exclusion Criteria

Non-English speaking
I am willing and able to give informed consent.
My cancer is advanced or has spread, and I was diagnosed over 6 months ago.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-Intervention

Patient encounters are audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation before the intervention

3 months
10 visits per urologist

Intervention

Implementation of visual decision support tools for urologists

1 month

Post-Intervention

Patient encounters are audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation after the intervention

3 months
10 visits per urologist

Follow-up

Participants are monitored for changes in patient-physician communication and decision-making

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Visual
Trial Overview The study tests visual decision support tools designed for cancer surgeons. Surgeons' discussions about surgery risks/benefits and their recommendations will be compared before and after the intervention using recorded patient encounters.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Physician participantsExperimental Treatment1 Intervention
Group II: Patient participantsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

UNC Lineberger Comprehensive Cancer Center

Lead Sponsor

Trials
377
Recruited
95,900+

Citations

Comprehension, utility, and preferences of prostate cancer ...Visual timelines of patient-reported outcomes (PRO) can help prostate cancer survivors manage longitudinal data, compare with population ...
Effect of different visual presentations on the comprehension ...Two studies on the communication of prostate cancer prognosis screening outcomes found no association between the type of presentation and ...
Visualization Co-Design with Prostate Cancer Survivors ...Visualizing patient-reported outcomes overtime has become a common strategy to help patients track their health. However, traditional line graphs and bar ...
Prostate Cancer Survivors Weigh In on Visual Timelines of ...Researchers assessed 4 prototypes of visual timelines for prostate cancer survivorship to determine which was best understood by survivors.
prospective-iterative-data-visualization-study-to-enhance- ...Many patients with PC and caregivers struggle to interpret complex scientific data about PC treatments.1 This hinders their ability to make informed ...
Enhancing Data Completeness in Early Detection Pathway ...Enhancing data completeness in early detection pathway of prostate cancer: integration of a dashboard-driven feedback tool to improve quality of care.
A visual active learning system for the assessment of ...We present a visual active learning system that enables physicians to label the well-being state of patient histories suffering prostate cancer. The labeled ...
Prostate Clinical Outlook Visualization System for Patients ...The PCOVS aims to support the patient and the clinician with a tool to visualize the likely outcomes using institutional, patient specific data for comparing ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security